Prostacyclin and vascular function: Implications for hypertension and atherosclerosis
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 48 (3) , 323-344
- https://doi.org/10.1016/0163-7258(90)90052-4
Abstract
No abstract availableKeywords
This publication has 196 references indexed in Scilit:
- The role of nitric oxide and cGMP in platelet adhesion to vascular endotheliumPublished by Elsevier ,2005
- Stimulation of prostacyclin formation by the platelet-derived growth factor — an important pathomechanism for atherogenesis?Experimental pathology, 1987
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3)Biochemical and Biophysical Research Communications, 1983
- Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophilsBiochemical and Biophysical Research Communications, 1983
- Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aortaBiochemical and Biophysical Research Communications, 1982
- Deleterious Effects of Hydralazine in Patients with Pulmonary HypertensionNew England Journal of Medicine, 1982
- Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic AgentNew England Journal of Medicine, 1981
- An Acute Effect of Cigarette Smoking on Platelet FunctionCirculation, 1973